Dr. Reyk Horland, CEO of TissUse GmbH 

1. Describe your company.   

TissUse GmbH is setting new standards in drug research with its patented Multi-Organ-Chip technology. We enable real-time analysis of human tissue for the pharmaceutical, chemical, and cosmetics industries, accelerate healthcare innovations, reduce animal testing, and promote the development of personalized medicine. Based in Berlin, we are actively shaping the future of biotechnology.


2. Why are you involved as a Berlin-Partner? 

TissUse is active as a partner in Berlin because the city offers a biotech network that perfectly aligns with our mission to drive healthcare innovations. The strong network of research institutions and industry in Berlin enables us to form effective collaborations, expand our reach, and support the advancement of our groundbreaking Multi-Organ-Chip technology platform. 


3. What topics drive you in relation to your industry?  

TissUse is driven by the vision of revolutionizing the drug development process with our innovative Multi-Organ-Chip technology. Our focus areas include optimizing the development of pharmaceutical, chemical, and cosmetic products, improving the prediction of chemical effects and metabolic processes, and reducing animal testing. Our goal is to optimize preclinical insights and enable personalized medicine to achieve better patient outcomes, while always adhering to sustainability and ethical standards in healthcare.

4. What makes Berlin special for you?  

Berlin is a global center for innovation and biotechnology. The dynamic start-up scene, access to top-notch research institutions, and central location in Europe make the city the ideal location for TissUse. The collaborative environment in Berlin fosters groundbreaking technological developments, such as our Multi-Organ-Chip platform, and allows us to push the boundaries of drug research and product development while contributing to the city's growing biotech landscape.

5. Why is Berlin attractive for your company?  

Berlin is a significant biotech hub that provides TissUse with an ideal environment for collaboration, innovation, and global access. The strategic location in the heart of Europe enables connectivity to international markets and makes the city a perfect location for our technology. Berlin's strong biotech infrastructure, access to leading research institutions, and a rich talent pool support the advancement of our technology for the pharmaceutical, chemical, and cosmetics industries, as well as our growth in the field of personalized medical solutions.

6. What does Berlin stand for to you?

Berlin stands for innovation, diversity, and progress—values that are closely linked to TissUse's mission. As the birthplace of our visionary Multi-Organ-Chip technology, Berlin embodies the connection between scientific excellence and entrepreneurial spirit. The city's commitment to sustainable practices and ethical research aligns with our goal of developing advanced, animal-free testing solutions that directly benefit healthcare and society.

7. How does your company implement the topic of sustainability?

With our unique Multi-Organ-Chip platform, we reduce the need for animal testing and offer a more ethical and environmentally friendly approach to drug testing. Our technology enables the prediction of chemical effects and their metabolism on human tissue, optimizes preclinical tests, and reduces resource consumption. As a Berlin-based company, we align with the city's commitment to sustainable practices and contribute through our innovations to a greener and more ethical future in healthcare.